Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan

This publication has 8 references indexed in Scilit:

• Sucrose Formulated Recombinant Human Antihemophilic Factor VIII Is Safe and Efficacious for Treatment of Hemophilia A in Home Therapy
  Thrombosis and Haemostasis, 2000
• Human recombinant DNA‐derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5‐year study of home therapy
  Haemophilia, 1999
• New-variant Creutzfeldt-Jakob disease and treatment of haemophilia
  The Lancet, 1997
• Transmission of Hepatitis A to Patients with Hemophilia by Factor VIII Concentrates Treated with Organic Solvent and Detergent To Inactivate Viruses
  Annals of Internal Medicine, 1994
• Investigation of an Outbreak of Hepatitis A in Irish Haemophilia A Patients
  Published by Wiley ,1994
• The Use of Purified Clotting Factor Concentrates in Hemophilia
  Published by American Medical Association (AMA) ,1989
• Factor concentrates for treatment of hemophilia: which one to choose? [see comments]
  Blood, 1989
• HTLV-III SEROPOSITIVITY IN EUROPEAN HAEMOPHILIACS EXPOSED TO FACTOR VIII CONCENTRATE IMPORTED FROM THE USA
  The Lancet, 1984